Nufymco

Ranibizumab-leyk · Zydus Pharmaceuticals USA Inc.
PRESCRIPTION ONLY (USA)

Nufymco ingredients

Active ingredientStrength
Ranibizumab.5 mg/.05mL, .3 mg/.05mL

What Nufymco is used for

Nufymco is a specialist medicine (vascular endothelial growth factor inhibitor). Its approved uses are listed on the official FDA label below.

Key facts

Brand
Nufymco
Generic name
Ranibizumab-leyk
Made by
Zydus Pharmaceuticals USA Inc.
Forms
Injection, Solution
Given
Intravitreal
Drug class
Vascular Endothelial Growth Factor Inhibitor
FDA approval
Biologic licence (BLA) BLA761473
On the US market since
2026

Official information

In India

Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.

Common questions

What is Nufymco?

Nufymco (Ranibizumab-leyk) is a specialist medicine made by Zydus Pharmaceuticals USA Inc., approved by the US FDA.

What are the ingredients of Nufymco?

Nufymco contains Ranibizumab (.5 mg/.05mL, .3 mg/.05mL).

From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.

← All specialty medicines, USA

For information only, not medical advice. This page is a plain-language summary written from standard prescribing information and the public guides linked below. Brands sometimes change their formula, so always check the composition printed on the pack. Doses here are typical adult doses; yours may differ. Do not start, stop or change a medicine without your doctor or pharmacist, and keep all medicines away from children. In an emergency, call 112 (India) or your local emergency number.